Skip to main content

Anupam Verma, MD

English, Hindi, Gujarati
Pediatric Hematology Oncology
Board Certifications:
American Board of Pediatrics, American Board of Pediatric - Hematology Oncology
Areas of Clinical Interest:
Pediatric and young adult acute leukemias, high risk leukemia, relapsed/refractory leukemia, leukemia in children with Down syndrome, clinical trial development in childhood leukemia, inherited bone marrow failure syndromes

Fellowship: Pediatric Hematology Oncology, University of Utah, Salt Lake City, UT (2012)
Chief Resident: Pediatrics, Brookdale University Hospital Medical Center, Brooklyn, NY (2005)
Residency: Pediatrics, Brookdale University Hospital Medical Center, Brooklyn, NY (2005)
Residency: Pediatrics, All India Institute of Medical Science, New Delhi, India (2002)
Residency: Pediatrics, M S University of Baroda Medical College, India (2000)
Medical School: M S University of Baroda Medical College, India (1996)

Clinic Locations: Fairfax, Fairfax CCBD

Keystone Publications:

Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome (ML-DS). Blood Adv. 2023 Feb. PMID: 36735769

Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study. Leukemia. 2023 May. PMID: 36813993

Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. Infect Control Hosp Epidemiol. 2022. PMID: 35465865

Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia. Blood Lymphat Cancer, 2021. P MCID: PMC8064615

PEGylated E. Coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to  Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi Availability. Pediatr Hematol  Oncol, 2019.

Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management after Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Network Open, 2021.

Kids-DOTT Trial Investigators and the ATLAS Group. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked  Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022. PMID: 35015038

Where did you grow up?
I grew up in the state of Gujarat in India.
Why did you become a doctor and why did you choose your specialty?
Since childhood I wanted to be a physician. I was moved by a teenager who was a football player and had acute myeloid leukemia (AML) during my pediatric rotation in India. My goal in moving to the US was to do research in childhood acute leukemia in order to improve survival outcomes in children and young adults.
How long have you practiced in the Washington, DC area and what do you like most about it?
I moved from Salt Lake City, Utah recently. I like the diversity of the patient population here in the DMV area.
What do you most enjoy doing outside of your clinical practice, when you’re not working?
Outside of clinical practice, I like being in nature. I enjoy hiking and exploring the various State and National Parks. I also like to cook, watch movies, and yoga.
Do you volunteer? If so, where?
I volunteer at my daughter’s high school on the diversity, equity, and inclusion board on the PTSA.
Describe your proudest accomplishment as a provider and/or in your personal life:
I am privileged and honored to be part of the lives of many children and families during their cancer fights.
If you weren’t a doctor, what profession would you most likely be doing and why?
If I was not a doctor, I would have been an attorney.